Moderna, Inc. officer Stephen Hoge is set to sell 318 shares of the company's common stock on 09/03/2024, with an aggregate market value of $24,482.50. The shares were acquired on 08/30/2024 as part of a restricted stock vesting and are considered compensation for Hoge. This transaction follows a series of sales over the past three months, where a total of 30,893 shares were sold for gross proceeds of $3,981,673.07.

Moderna, Inc. officer Stephen Hoge is set to sell 318 shares of the company's common stock on 09/03/2024, with an aggregate market value of $24,482.50. The shares were acquired on 08/30/2024 as part of a restricted stock vesting and are considered compensation for Hoge. This transaction follows a series of sales over the past three months, where a total of 30,893 shares were sold for gross proceeds of $3,981,673.07.